Unilateral sub-acute to chronic primary rotator cuff syndrome in patients who have never undergone surgical intervention or shoulder injection Rotator cuff syndrome, Subacromial pain syndrome, Telerehabilitation, Telerehabilitation plus conventional therapy, shoulder pain, shoulder function
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18 years or older. 2. Diagnosed with Rotator Cuff Syndrome by a physiatrist or orthopedic specialist and presenting with shoulder pain persisting for at least 1 month but not more than 12 months. 3. Experiencing mild to moderate pain, defined as a pain score between 4 and 6 on the Numeric Pain Scale (NPS). 4. No history of shoulder surgery, corticosteroid injection, or other shoulder interventions prior to participation. 5. Able to participate in the telerehabilitation program, and able to travel to the hospital for the standard rehabilitation program. Participants may be accompanied by a caregiver if they require assistance using the telerehabilitation platform or traveling to the hospital.
Exclusion criteria
Exclusion criteria: 1. Patients with bilateral rotator cuff syndrome. 2. Patients with complete rotator cuff tears, diagnosed by ultrasonography or magnetic resonance imaging (MRI). 3. Patients with secondary rotator cuff syndrome caused by major trauma or other underlying conditions, such as Stroke and Systemic inflammatory diseases, e.g., rheumatoid arthritis 4. Patients with calcific tendinitis, confirmed by ultrasonography or MRI. 5. Patients with cognitive impairments or any other conditions that impair their ability to follow instructions, as determined by a TMSE (Thai Mental State Examination) score of less than 25 or as clinically evaluated by the physician. 6. Patients with medical conditions that contraindicate exercise, such as End-stage cancer and End-stage heart disease. 7. Patients with communication difficulties that may interfere with rehabilitation participation. 8. Patients with a history of allergy to naproxen or paracetamol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional capacity of the shoulder at baseline, 4 week after the intervention, at 8 week after the intervention (the end of the treatment period) and at 12 week after the intervention (the end of the study) Shoulder pain and disability index (SPADI) | — |
Secondary
| Measure | Time frame |
|---|---|
| Shoulder pain at baseline, 4 week after the intervention, at 8 week after the intervention (the end of the treatment period) and at 12 week after the intervention (the end of the study) Numerical pain scale (NPS),Functional range of motion of shoulder at baseline, 4 week after the intervention, at 8 week after the intervention (the end of the treatment period) and at 12 week after the intervention (the end of the study) 3 function-related test,Pain killer usage frequency at baseline, 4 week after the intervention, at 8 week after the intervention (the end of the treatment period) and at 12 week after the intervention (the end of the study) Frequency of pain killer use,Depression at baseline, 4 week after the intervention, at 8 week after the intervention (the end of the treatment period) and at 12 week after the intervention (the end of the study) PHQ-9,Anxiety at baseline, 4 week after the intervention, at 8 week after the intervention (the end of the treatment period) and at 12 week after the intervention (the end of the study) GAD-7,Exercise compliance 4 week after the intervention and at 8 week after the intervention (the end of the treatment period) % compliance of exercise for the treatment period ,Exercise accuracy 4 week after the intervention and at 8 week after the intervention (the end of the treatment period) % Exercise correction evaluated by therapist | — |
Countries
Thailand
Contacts
Faculty of medicine Siriraj hospital, Mahidol university